Meta description: A new clinical trials entry registers laser acupuncture for carpal tunnel symptoms in breast cancer patients, signaling regulatory interest in device based pain management.
Publication date context: February 13, 2026. A ClinicalTrials.gov record from Cairo University documents a laser based acupuncture device used to address carpal tunnel syndrome in patients with breast cancer. The study lists traditional physical therapy as a comparator and indicates the status not yet recruiting. The sponsor and trial link are provided for reference.
In this article
What changed?
The trial record on ClinicalTrials.gov identifies a laser acupuncture technique as the device based intervention for carpal tunnel syndrome in breast cancer patients. The entry lists traditional physical therapy as a comparator and names Cairo University as sponsor. The study status is not yet recruiting. The page provides a link to the full record for reference. This disclosure aligns with the regulatory practice of documenting device based approaches in specific patient populations before any results are reported.
Who is affected?
Clinical researchers and clinicians in oncology care and rehabilitation may track this trial as part of device assessment for CTS management. Patients with carpal tunnel symptoms in the context of breast cancer may be indirectly affected by future results, should the study progress. Regulatory professionals and device manufacturers may monitor the page for updates and potential submissions. Healthcare institutions that maintain CTS management programs may consider how laser acupuncture could integrate with existing therapies if evidence supports value and safety.
What device features are disclosed?
The entry describes the intervention as a laser acupuncture technique. No performance data or safety claims are provided in the record. Device characteristics such as laser type, wavelength, dosage or session structure are not disclosed in the available text. Sponsorship is Cairo University and the study is not yet recruiting. The absence of technical specifications means readers should avoid assumptions about device classification or regulatory pathways beyond the stated scope of the trial.
What is the regulatory context?
Public trial records on ClinicalTrials.gov serve as a timeline of device investigations and clinical exploration. The listing does not confirm regulatory clearance or approval for clinical use. It signals early stage research in a patient group with breast cancer and suggests potential regulatory pathways if data are collected and submitted in the future. Stakeholders should interpret the record as an information placeholder rather than a statement of device market authorization or efficacy.
What are next steps?
Researchers are expected to finalize the protocol and initiate recruitment if regulatory and ethical approvals progress. Clinicians should await trial updates and any published results before considering practice changes. Device developers may prepare for future submissions if results indicate viable CTS management options, while regulatory teams assess safety and performance data when it becomes available.
- What is the focus of the trial? The record studies a laser based acupuncture method for carpal tunnel syndrome in breast cancer patients.
- Where is the trial registered? On ClinicalTrials.gov with identifier NCT07405008.
- What is the current status? Not yet recruiting.
- What intervention is studied? A laser acupuncture technique with traditional physical therapy listed as a comparator.
- Where can more details be found? See the ClinicalTrials.gov page linked in the source text.
Conclusion
This entry marks an early stage in a device based study for carpal tunnel syndrome in a distinctive patient group. No claims of efficacy or safety are made in the record. Stakeholders should monitor for updates as recruitment or data submissions unfold and should rely on official regulatory communications for any decisions related to device use.
Disclaimer
This article is intended for professionals. It is not legal advice. It is not medical advice. For regulatory or clinical decisions please consult official sources and qualified counsel.
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07405008?term=medical+device